REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 26th, 2016 • Cinven Capital Management (V) General Partner LTD • Services-commercial physical & biological research • New York
Contract Type FiledAugust 26th, 2016 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of August 10, 2016 by and among Medpace Holdings, Inc., a Delaware corporation (the “Company”), Fifth Cinven Fund (No. 1) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 2) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 3) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 4) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 5) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 6) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund Co-Investment Partnership, a general partnership formed under the laws of England and Wales, and Fifth Cinven Fund FCP-SIF, a Luxembourg fond commun de placement (collectively, “Cinven”), and Dr. August J. Troendle (“Dr. Troendle”) as of the date hereof.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 2nd, 2015 • Cinven Capital Management (V) General Partner LTD • Pharmaceutical preparations • New York
Contract Type FiledNovember 2nd, 2015 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT dated as of October 21, 2015, between Concordia Healthcare Corp. (the “Company”), a corporation governed by the laws of the Province of Ontario, and Cinven Capital Management (V) General Partner Limited, a limited liability company incorporated in Guernsey (“Cinven”), CCM Co-Invest Limited Partnership, CCM Mezzanine Co-Invest Limited Partnership, Fifth Cinven Fund (No. 1) Limited Partnership, Fifth Cinven Fund (No. 2) Limited Partnership, Fifth Cinven Fund (No. 3) Limited Partnership, Fifth Cinven Fund (No. 4) Limited Partnership, Fifth Cinven Fund (No. 5) Limited Partnership, Fifth Cinven Fund (No. 6) Limited Partnership, Fifth Cinven Fund Co-Investment Partnership, Fifth Cinven Fund FCP-SIF (represented by Cinven Manco S.À.R.L.), Bhikhu Chhotabhai Kalidas Patel and Vijaykumar Chhotabhai Kalidas Patel (together the “Holders”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 22nd, 2017 • Cinven Capital Management (V) General Partner LTD • Services-commercial physical & biological research
Contract Type FiledAugust 22nd, 2017 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • August 26th, 2016 • Cinven Capital Management (V) General Partner LTD • Services-commercial physical & biological research
Contract Type FiledAugust 26th, 2016 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • November 2nd, 2015 • Cinven Capital Management (V) General Partner LTD • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2015 Company IndustryPursuant to Rule 13(d)-1(k)(l) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the common shares of Concordia Healthcare Corp.
GOVERNANCE AGREEMENTGovernance Agreement • November 2nd, 2015 • Cinven Capital Management (V) General Partner LTD • Pharmaceutical preparations • Ontario
Contract Type FiledNovember 2nd, 2015 Company Industry JurisdictionTHIS GOVERNANCE AGREEMENT (this “Agreement”) is dated and effective as of October 21, 2015 between and Concordia Healthcare Corp., a corporation governed under the Laws of the Province of Ontario (“Concordia”), Cinven Capital Management (V) General Partner Limited, a limited liability company incorporated in Guernsey whose registered office is at East Wing, Trafalgar Court, Les Banques, St Peter Port, Guernsey, GY1 3PP (“Cinven”), and the persons whose names are set out in Schedule E hereto (the “Cinven Shareholders”, together with each of their respective Permitted Transferees (as defined below). Concordia and the Cinven Shareholders are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
JOINT FILING AGREEMENTJoint Filing Agreement • June 22nd, 2017 • Cinven Capital Management (V) General Partner LTD • Services-commercial physical & biological research
Contract Type FiledJune 22nd, 2017 Company IndustryThe undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.